Ajooni Biotech (NSE:AJOONI) Tariff Resilience Score: 0/10 (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AJOONI Ajooni Biotech Ltd NSE:AJOONI
62 GF Score
Price ₹3.75
GF Value ₹6.23
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Ajooni Biotech Tariff Resilience Score?

Ajooni Biotech has the Tariff Resilience Score of 0, which implies that the company might have .

Ajooni Biotech has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Ajooni Biotech might have .

Ajooni Biotech  (NSE:AJOONI) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Ajooni Biotech Tariff Resilience Score Related Terms

NSE:AJOONI
62GF Score
Ajooni Biotech Ltd NSE:AJOONI
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ajooni Biotech (NSE:AJOONI) Overvalued in 2026?

Based on GuruFocus' analysis, Ajooni Biotech stock appears to be undervalued. The current stock price of ₹3.75 is trading 39.8% below its estimated GF Value™ of ₹6.23. GuruFocus considers Ajooni Biotech to be Possible Value Trap.

Key valuation signals for NSE:AJOONI:

  • Tariff Resilience Score: 0
  • GF Value™: ₹6.23 vs. price of ₹3.75 (39.8% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the NSE:AJOONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ajooni Biotech Business Description

Address House No. 1769, Phase 3B2, Mohali, PB, IND, 160055
Ajooni Biotech Ltd is engaged in providing animal health care solutions dedicated to improving the productivity of Dairy farmers and sustainably increasing livestock yields. The company's products of cattle feed include Gold Pashu Aahar, Buff Plus, 3 Star, 4 Star, Calf Starter, & Transition Plus, and its feed supplements include Calvit, Batisa, Liv, Min, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.
62GF Score

Get the complete analysis for NSE:AJOONI

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.75
Price
₹6.23
GF Value